Mechanisms of Disease: angiogenesis in inflammatory diseases (Q36984877)

17 August 2017

1 reference

title

Mechanisms of Disease: angiogenesis in inflammatory diseases (English)

1 reference

17 August 2017

0 references

1 reference

Zoltán Szekanecz

1

1 reference

17 August 2017

Alisa E Koch

series ordinal

2

1 reference

17 August 2017

publication date

1 November 2007

1 reference

Nature Clinical Practice Rheumatology

17 August 2017

published in

1 reference

17 August 2017

volume

3

1 reference

17 August 2017

issue

11

1 reference

17 August 2017

page(s)

635-643

1 reference

Evidence of IL-18 as a novel angiogenic mediator

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0647

IL-17 enhances the net angiogenic activity and in vivo growth of human non-small cell lung cancer in SCID mice through promoting CXCR-2-dependent angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0647

Synoviocyte-derived CXCL12 is displayed on endothelium and induces angiogenesis in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0647

CCL2 regulates angiogenesis via activation of Ets-1 transcription factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0647

Stromal cell-derived factor-1-CXC chemokine receptor 4 interactions play a central role in CD4+ T cell accumulation in rheumatoid arthritis synovium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0647

Vascular endothelial growth factor-induced signaling pathways in endothelial cells that mediate overexpression of the chemokine IFN-gamma-inducible protein of 10 kDa in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0647

Review: angiogenesis: implications for rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0647

7 January 2021

Chemokines and angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0647

7 January 2021

Angiogenesis and chemokines in rheumatoid arthritis and other systemic inflammatory rheumatic diseases.

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0647

7 January 2021

Angiogenesis inhibition: a review

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0647

7 January 2021

Angiogenesis in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0647

7 January 2021

Angiogenesis and arthritis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0647

7 January 2021

Inhibition of angiogenic pathways in rheumatoid arthritis: potential for therapeutic targeting.

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0647

7 January 2021

Signaling of vascular endothelial growth factor receptor-1 tyrosine kinase promotes rheumatoid arthritis through activation of monocytes/macrophages

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0647

7 January 2021

Endostatin gene transfer inhibits joint angiogenesis and pannus formation in inflammatory arthritis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0647

7 January 2021

Role of adhesion molecules in synovial inflammation

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0647

7 January 2021

Cytokines in rheumatoid arthritis. Potential targets for pharmacological intervention

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0647

7 January 2021

Update on cytokines in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0647

7 January 2021

Macrophages and their products in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0647

7 January 2021

Vascular endothelium and immune responses: implications for inflammation and angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0647

7 January 2021

VEGF/VEGFR signalling as a target for inhibiting angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0647

7 January 2021

Selective inhibition of vascular endothelial growth factor-mediated angiogenesis by cyclosporin A: roles of the nuclear factor of activated T cells and cyclooxygenase 2

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0647

7 January 2021

Upregulated hypoxia inducible factor-1alpha and -2alpha pathway in rheumatoid arthritis and osteoarthritis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0647

7 January 2021

Interleukin-15 Promotes Angiogenesisin Vivo

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0647

7 January 2021

Resolution of endothelial activation and down-regulation of Tie2 receptor in psoriatic skin after infliximab therapy

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0647

7 January 2021

Oncostatin M induces angiogenesis and cartilage degradation in rheumatoid arthritis synovial tissue and human cartilage cocultures

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0647

7 January 2021

Migration inhibitory factor mediates angiogenesis via mitogen-activated protein kinase and phosphatidylinositol kinase.

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0647

7 January 2021

MIF: a new cytokine link between rheumatoid arthritis and atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0647

7 January 2021

The Functional Role of the ELR Motif in CXC Chemokine-mediated Angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0647

7 January 2021

Capillary endothelial cell cultures: phenotypic modulation by matrix components

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0647

7 January 2021

Effect of interleukin-4 on vascular endothelial growth factor production in rheumatoid synovial fibroblasts.

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0647

7 January 2021

Identification of a human peripheral blood monocyte subset that differentiates into osteoclasts

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0647

7 January 2021

Angiogenesis promoted by vascular endothelial growth factor: regulation through alpha1beta1 and alpha2beta1 integrins

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0647

7 January 2021

Toll-like receptor 2 ligand mediates the upregulation of angiogenic factor, vascular endothelial growth factor and interleukin-8/CXCL8 in human rheumatoid synovial fibroblasts.

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0647

7 January 2021

Endothelial cell stimulating angiogenesis factor--a new biological marker for disease activity in ankylosing spondylitis?

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0647

7 January 2021

High serum vascular endothelial growth factor correlates with disease activity of spondylarthropathies

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0647

7 January 2021

Circulating angiogenesis inhibitor endostatin and positive endothelial growth regulators in patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0647

7 January 2021

Decreased monocyte-mediated angiogenesis in scleroderma

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0647

7 January 2021

Increased concentrations of the circulating angiogenesis inhibitor endostatin in patients with systemic sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0647

7 January 2021

Domain 1 of the urokinase-type plasminogen activator receptor is required for its morphologic and functional, beta2 integrin-mediated connection with actin cytoskeleton in human microvascular endothelial cells: failure of association in systemic scl

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0647

7 January 2021

Disease-associated increased HIF-1, alphavbeta3 integrin, and Flt-1 do not suffice to compensate the damage-inducing loss of blood vessels in inflammatory myopathies

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0647

7 January 2021

Vascular endothelial growth factor in acute Kawasaki disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0647

7 January 2021

Transforming growth factor-beta (TGF-beta) expression and interaction with proteinase 3 (PR3) in anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0647

7 January 2021

Tissue and Serum Angiogenic Activity Is Associated With Low Prevalence of Ischemic Complications in Patients With Giant-Cell Arteritis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0647

7 January 2021

Semaphorin-3A and semaphorin-3F work together to repel endothelial cells and to inhibit their survival by induction of apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0647

7 January 2021

Deactivation of endothelium and reduction in angiogenesis in psoriatic skin and synovium by low dose infliximab therapy in combination with stable methotrexate therapy: a prospective single-centre study

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0647

7 January 2021

Treatment of active psoriatic arthritis with the PPARgamma ligand pioglitazone: an open-label pilot study

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0647

7 January 2021

Inhibition of angiogenesis by interleukin-4 gene therapy in rat adjuvant-induced arthritis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0647

7 January 2021

Therapies directed at vascular endothelial growth factor

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0647

7 January 2021

Blockade of the chemokine receptor CXCR2 inhibits pancreatic cancer cell-induced angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0647

7 January 2021

Design and synthetic considerations of matrix metalloproteinase inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0647

7 January 2021

The role of COX-2 in angiogenesis and rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0647

7 January 2021

Identifiers

DOI

10.1038/NCPRHEUM0647

1 reference

Dimensions Publication ID

17 August 2017

1005255561

0 references

1 reference